# Open Label Study of DS-5573a

> **NCT02192567** · PHASE1 · TERMINATED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 19 (actual)

## Conditions studied

- Advanced Solid Malignant Tumors

## Interventions

- **DRUG:** DS-5573a

## Key facts

- **NCT ID:** NCT02192567
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192567, "Open Label Study of DS-5573a". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02192567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*